Findings from two studies, followed by a panel discussion featuring clinicians, researchers, and people with lived/living experience
Measuring meaningful outcomes in trials of medications for methamphetamine use disorder
Findings from a systematic review, and lived and living experience perspectives
Community-led approaches to drug monitoring and early warning: Lessons from the around the world
NCCRED and AIVL hosted a discussion on how lived and living experience perspectives can be meaningfully embedded in drug monitoring systems.
Next steps in prescription stimulants as a treatment for methamphetamine use disorder: Clinical implications of the LiMA trial
A discussion on the findings of the trial an expert panel discussion with clinicians, researchers and representatives with lived/living experience, and a live Q&A.
Digital interventions for methamphetamine use & First Nations people
A discussion on how digital health tools are being designed in partnership with First Nations communities to deliver culturally safe and accessible care.
New & upcoming treatments for methamphetamine
New research is generating promising signals for pharmacological and psychosocial treatments for methamphetamine dependence and withdrawal.
Sign up here to keep up to date on all of our upcoming webinars and events
